Wedge Capital Management L L P Pacira Bio Sciences, Inc. Transaction History
Wedge Capital Management L L P
- $5.57 Billion
- Q2 2024
A detailed history of Wedge Capital Management L L P transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 51,500 shares of PCRX stock, worth $997,555. This represents 0.03% of its overall portfolio holdings.
Number of Shares
51,500
Previous 56,383
8.66%
Holding current value
$997,555
Previous $1.65 Million
10.56%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
289Shares Held
48.6MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$153 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$99 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$37.1 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$36.9 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$36.5 Million0.09% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $888M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...